Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person WDR5 and DPY30 interact with the RBBP5:ASH2L heterodimer and...

Class:IdSummation:9675703
_displayNameWDR5 and DPY30 interact with the RBBP5:ASH2L heterodimer and...
_timestamp2023-02-10 15:21:03
created[InstanceEdit:9675717] Orlic-Milacic, Marija, 2020-02-04
literatureReference[LiteratureReference:4687068] PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex
[LiteratureReference:9675715] WRAD: enabler of the SET1-family of H3K4 methyltransferases
[LiteratureReference:9675716] Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation
[LiteratureReference:9675721] A novel non-SET domain multi-subunit methyltransferase required for sequential nucleosomal histone H3 methylation by the mixed lineage leukemia protein-1 (MLL1) core complex
modified[InstanceEdit:9675722] Orlic-Milacic, Marija, 2020-02-04
[InstanceEdit:9821611] Orlic-Milacic, Marija, 2022-12-09
[InstanceEdit:9821876] Orlic-Milacic, Marija, 2022-12-13
[InstanceEdit:9823550] Orlic-Milacic, Marija, 2023-01-06
[InstanceEdit:9828080] Orlic-Milacic, Marija, 2023-02-10
textWDR5 and DPY30 interact with the RBBP5:ASH2L heterodimer and together form the WRAD complex, which functions as a core subcomplex of all mammalian KMT2 histone methyltransferase complexes (Cho et al. 2007, Patel et al. 2011, Shinsky et al. 2015, reviewed by Ernst and Vakoc 2012). WDR5 directly interacts with RBBP5 (Odho et al. 2010), while DPY30 directly binds to ASH2L (Cho et al. 2007). RBBP5, ASH2L, and DPY30 may form a subcomplex prior to WDR5 binding (van Nuland et al. 2013). Based on stoichiometric analysis, DPY30 likely exists as a homo-oligomer in the WRAD complex (van Nuland et al. 2013).
(summation)[Reaction:9675214] Formation of the WRAD complex [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by WDR5 and DPY30 interact with the RBBP5:ASH2L heterodimer and... (9675703)